Drug Markets/Iron Sucrose

Iron Sucrose

4 NDCs across 2 manufacturers|0 Generic,4 Brand

Iron Sucrose is used to treat iron-deficiency anemia and hematologic pregnancy complications, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Nov 6, 2000, and the first generic was approved Aug 8, 2025. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient.

Iron Sucrose is available as 4 NDCs from 2 manufacturers (0 generic, 4 brand), with NADAC prices from $12.21 to $12.53 per MLa 3% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

4

0G / 4B

Manufacturers

2

competing in market

Price Spread

$12.21 – $12.53

per ML

7d Activity

4 flat

avg +0.0% WoW · of 4 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

4 NDCs total, 4 shown

Frequently Asked Questions

What is Iron Sucrose used to treat?

Iron Sucrose is used to treat iron-deficiency anemia and hematologic pregnancy complications, per the National Library of Medicine's MED-RT classification.

When did Iron Sucrose become available as a generic?

FDA approved the first generic Iron Sucrose (ANDA) on Aug 8, 2025. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How many Iron Sucrose products are on the market?

The Iron Sucrose drug market contains 4 NDCs from 2 manufacturers — 0 generic and 4 brand products.

What is the price range for Iron Sucrose?

NADAC reference prices for Iron Sucrose range from $12.2067 to $12.5305 per ML — a 3% difference between cheapest and most expensive.

Which manufacturers make Iron Sucrose?

2 manufacturers list Iron Sucrose in NADAC. Ranked by number of NDCs, the largest are American Regent, Inc. (3), Fresenius Medical Care Holdings, Inc. (1).